UK: First Graphene has announced a third trial at Breedon Group’s Hope Cement Works to test an optimised formulation of its PureGRAPH-CEM product under full-scale production conditions. The trial aims to further improve the performance of graphene nanoplatelets in cement production using practical experiences obtained from the previous two trials. The third trial is based on a PureGRAPH grade with a particle size distribution and morphology optimised for use in cement grinding mills, designed for direct addition to the mill without the need for additional equipment. The trial will last eight hours and involves close monitoring of cement fineness during the process. It will use just over 2t of the graphene product in up to 1000t of cement, according to the company. The trial is scheduled to start in the second quarter of 2024.
First Graphene to trial new graphene product at Breedon's Hope Cement Works
Written by Global Cement staff
Published in
Global Cement News
Tagged under
Register for the Global Cement Weekly email newsletter
Global Cement Weekly is Global Cement’s weekly email newsletter. Keep up to date with cement industry news, analysis, diary dates and news of people in the sector.
URL: https://globalcement.com/news/item/17248-first-graphene-to-trial-new-graphene-product-at-breedon-s-hope-cement-works
© 2024 Pro Global Media Ltd. All rights reserved.